⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata